Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like 10 Biotechs Tackling Form of Aggressive Brain Cancer July 20, 2017 Bay Area's Versartis Cuts Jobs and Cancels Contracts as it Evaluates a Path Forward October 26, 2017 Takeda Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston July 17, 2017
